Pantoprazole Sodium (eq. Pantoprazole 40mg) Tablets (Enteric Coated) — Tablets
WHO-GMP Certified Commercial Pack · Product Code: AKP-008

Pantoprazole Sodium (eq. Pantoprazole 40mg) Tablets (Enteric Coated)

Formulation Overview: Standard 40 mg delayed-release gastro-resistant tablet delivering sustained H+/K+-ATPase blockade for healing peptic ulcers and preventing NSAID-induced mucosal injury. Formulated with Pantoprazole Sodium Sesquihydrate IP (eq. Pantoprazole 40 mg) (40 mg) in Enteric-Coated Tablets dosage form under Gastroenterology & PPIs, manufactured to IP / BP / USP Compendial standards and supplied in 10 x 10 Alu-Alu Blister Pack with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
Item Code (SKU)AKP-008
Therapeutic SectorGastroenterology & PPIs
Dosage FormEnteric-Coated Tablets
Active IngredientPantoprazole Sodium Sesquihydrate IP (eq. Pantoprazole 40 mg)
Strength / Purity40 mg
Clinical IndicationErosive esophagitis, duodenal and gastric ulcers, Zollinger-Ellison syndrome, and H. pylori eradication regimens
Specification StandardIP / BP / USP Compendial
Packaging Format10 x 10 Alu-Alu Blister Pack
Shelf Life24–36 Months
Storage ConditionsStore below 25°C, protect from moisture & direct sunlight
Minimum Order Quantity1000 Packs
Regulatory / Analytical DocsFull eCTD / ACTD Modules 1–5 + Zone IVb Stability Available
African & Global NRA ReadinessNAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA
Stock AvailabilityIn Stock · Immediate Commercial Dispatch
Supply StatusCommercial Export Ready

Related Tablets & Gastroenterology & PPIs